Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

148
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
148
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

160
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
160
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new first line choice? Has clopidogrel superseded aspirin for secondary prevention following selected minor ischaemic strokes?

Internal medicine journal·2026
Same author

Pre-implementation safety evaluation of an AI decision-support system for surgical antimicrobial prophylaxis.

Internal medicine journal·2026
Same author

The relationship between time to urgent or emergency pacemaker implantation and entry into residential aged care or death in older adults.

Aging clinical and experimental research·2026
Same author

NETosis associates with human TB lung tissue destruction and disease pathogenesis.

EMBO molecular medicine·2026
Same author

Education Research: Quality of Narrative Feedback Generated by a Large Language Model Compared With Expert Faculty for Case-Based Learning in Neurology Education.

Neurology. Education·2026
Same author

Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents.

BMJ neurology open·2026
Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026
Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026
Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026
Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026
Same journal

Thirty-day mortality among patients admitted due to acute myocardial infarction during the dates of the Cardiac Society of Australia and New Zealand Annual Scientific Meeting.

Internal medicine journal·2026
Same journal

Denosumab discontinuation and fracture risk: getting the balance right.

Internal medicine journal·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Push or pull? Digital notification platform implementation reduces dysglycaemia.

Shrirajh Satheakeerthy1,2, Brandon Stretton1,2,3,4, Andrew E C Booth1,2

  • 1Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Internal Medicine Journal
|September 4, 2024
PubMed
Summary
This summary is machine-generated.

A new digital notification system proactively alerts clinicians to patient dysglycaemia, improving care. This approach reduced dysglycaemia rates in a tertiary hospital study, suggesting benefits for healthcare information delivery.

Keywords:
digital healthefficiencyoutcomespragmaticworkflow

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K

Area of Science:

  • Clinical Informatics
  • Healthcare Delivery Science
  • Patient Safety

Background:

  • Traditional healthcare relies on clinicians actively retrieving data from electronic medical records.
  • Proactive information delivery to clinicians has the potential to enhance patient care and outcomes.
  • Managing dysglycaemia (abnormal blood glucose levels) is a critical aspect of hospital care.

Purpose of the Study:

  • To evaluate the effectiveness of a clinician-designed digital notification platform for flagging dysglycaemia.
  • To compare dysglycaemia rates in patients before and after the implementation of the notification system.
  • To explore the impact of proactive information delivery on clinical practice and patient outcomes.

Main Methods:

  • A digital notification platform was developed collaboratively by clinicians.
  • The platform was implemented in a tertiary hospital setting.
  • A study involving 112 patients compared outcomes pre- and post-implementation.

Main Results:

  • The post-implementation group showed significantly lower rates of dysglycaemia (1.1%) compared to the pre-implementation group (2.5%).
  • The difference in dysglycaemia rates was statistically significant (P = 0.038).
  • The study demonstrated the feasibility and positive impact of the digital notification system.

Conclusions:

  • Proactive information delivery via digital platforms can improve patient care by addressing critical conditions like dysglycaemia.
  • The findings support the adoption of push notification systems for managing specific clinical issues.
  • This approach to information delivery warrants consideration for broader applications across various healthcare domains.